| 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 原药(元) | 533,282,559.08 | 233,010,122.78 | 496,662,029.11 | 276,024,289.45 |
| 制剂(元) | 674,073,975.40 | 583,164,366.50 | 693,587,046.40 | 504,835,281.43 |
| 其他(元) | 87,394,413.05 | 48,638,614.21 | 171,730,849.88 | - |
| 营业成本(元) | ||||
| 原药(元) | 443,696,609.51 | 184,511,916.48 | 344,779,977.97 | 167,853,525.41 |
| 制剂(元) | 527,214,594.35 | 394,439,847.04 | 532,271,635.59 | 360,362,841.44 |
| 其他(元) | 65,501,065.15 | 29,206,442.90 | 141,134,355.90 | - |
| 毛利(元) | ||||
| 原药(元) | 89,585,949.57 | 48,498,206.30 | 151,882,051.14 | 108,170,764.04 |
| 制剂(元) | 146,859,381.05 | 188,724,519.46 | 161,315,410.81 | 144,472,439.99 |
| 其他(元) | 21,893,347.90 | 19,432,171.31 | 30,596,493.98 | - |
| 毛利率(%) | ||||
| 原药(%) | 16.80 | 20.81 | 30.58 | 39.19 |
| 制剂(%) | 21.79 | 32.36 | 23.26 | 28.62 |
| 其他(%) | 25.05 | 39.95 | 17.82 | - |
| 收入构成(%) | ||||
| 原药(%) | 41.19 | 26.94 | 36.47 | 35.35 |
| 制剂(%) | 52.06 | 67.43 | 50.92 | 64.65 |
| 其他(%) | 6.75 | 5.62 | 12.61 | - |
| 毛利构成(%) | ||||
| 原药(%) | 34.68 | 18.90 | 44.18 | 42.82 |
| 制剂(%) | 56.85 | 73.53 | 46.92 | 57.18 |
| 其他(%) | 8.47 | 7.57 | 8.90 | - |